AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1086490, encodeId=134410864903c, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086489, encodeId=1cae108648914, content=我的文章大概有几分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850072, encodeId=14938500e261, content=这个杂志已经被剔除sci了 articles appearing in the journal are indexed in pubmed/medline; current contents, education; current contents, life sciences; international pharmaceutical abstracts; current index to journals in education; and by proquest and ebsco. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Tue Mar 05 22:40:06 CST 2019, time=2019-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541242, encodeId=f91c541242d0, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516221, encodeId=a6b751622168, content=markwangzhuo 2012-04-03 发表:: 研究方向：药学教学研究;药学教学设计; 投过两次，3天后都被拒了；第一次是因为不符合其范围；第二次说缺乏原创。国内的教学文章的确缺乏创新，该期刊希望具有中国特色的稿件。目前中国人发的稿件确实很好。, beContent=wangzhuo 2012-04-03 发表:: 研究方向：药学教学研究;药学教学设计; 投过两次，3天后都被拒了；第一次是因为不符合其范围；第二次说缺乏原创。国内的教学文章的确缺乏创新，该期刊希望具有中国特色的稿件。目前中国人发的稿件确实很好。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69061653887, createdName=mxg330, createdTime=Thu Oct 22 02:11:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487706, encodeId=721248e7067e, content=投过两次，3天后都被拒了；第一次是因为不符合其范围；第二次说缺乏原创。国内的教学文章的确缺乏创新，该期刊希望具有中国特色的稿件。目前中国人发的稿件确实很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=011859642, createdName=wangzhuo, createdTime=Tue Apr 03 00:44:00 CST 2012, time=2012-04-03, status=1, ipAttribution=)]

2021-12-29 MS68862005

投nature需要什么准备？

39 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1086490, encodeId=134410864903c, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086489, encodeId=1cae108648914, content=我的文章大概有几分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850072, encodeId=14938500e261, content=这个杂志已经被剔除sci了 articles appearing in the journal are indexed in pubmed/medline; current contents, education; current contents, life sciences; international pharmaceutical abstracts; current index to journals in education; and by proquest and ebsco. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Tue Mar 05 22:40:06 CST 2019, time=2019-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541242, encodeId=f91c541242d0, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516221, encodeId=a6b751622168, content=markwangzhuo 2012-04-03 发表:: 研究方向：药学教学研究;药学教学设计; 投过两次，3天后都被拒了；第一次是因为不符合其范围；第二次说缺乏原创。国内的教学文章的确缺乏创新，该期刊希望具有中国特色的稿件。目前中国人发的稿件确实很好。, beContent=wangzhuo 2012-04-03 发表:: 研究方向：药学教学研究;药学教学设计; 投过两次，3天后都被拒了；第一次是因为不符合其范围；第二次说缺乏原创。国内的教学文章的确缺乏创新，该期刊希望具有中国特色的稿件。目前中国人发的稿件确实很好。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69061653887, createdName=mxg330, createdTime=Thu Oct 22 02:11:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487706, encodeId=721248e7067e, content=投过两次，3天后都被拒了；第一次是因为不符合其范围；第二次说缺乏原创。国内的教学文章的确缺乏创新，该期刊希望具有中国特色的稿件。目前中国人发的稿件确实很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=011859642, createdName=wangzhuo, createdTime=Tue Apr 03 00:44:00 CST 2012, time=2012-04-03, status=1, ipAttribution=)]

2021-12-27 小动量

我的文章大概有几分？

46 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1086490, encodeId=134410864903c, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086489, encodeId=1cae108648914, content=我的文章大概有几分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850072, encodeId=14938500e261, content=这个杂志已经被剔除sci了 articles appearing in the journal are indexed in pubmed/medline; current contents, education; current contents, life sciences; international pharmaceutical abstracts; current index to journals in education; and by proquest and ebsco. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Tue Mar 05 22:40:06 CST 2019, time=2019-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541242, encodeId=f91c541242d0, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516221, encodeId=a6b751622168, content=markwangzhuo 2012-04-03 发表:: 研究方向：药学教学研究;药学教学设计; 投过两次，3天后都被拒了；第一次是因为不符合其范围；第二次说缺乏原创。国内的教学文章的确缺乏创新，该期刊希望具有中国特色的稿件。目前中国人发的稿件确实很好。, beContent=wangzhuo 2012-04-03 发表:: 研究方向：药学教学研究;药学教学设计; 投过两次，3天后都被拒了；第一次是因为不符合其范围；第二次说缺乏原创。国内的教学文章的确缺乏创新，该期刊希望具有中国特色的稿件。目前中国人发的稿件确实很好。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69061653887, createdName=mxg330, createdTime=Thu Oct 22 02:11:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487706, encodeId=721248e7067e, content=投过两次，3天后都被拒了；第一次是因为不符合其范围；第二次说缺乏原创。国内的教学文章的确缺乏创新，该期刊希望具有中国特色的稿件。目前中国人发的稿件确实很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=011859642, createdName=wangzhuo, createdTime=Tue Apr 03 00:44:00 CST 2012, time=2012-04-03, status=1, ipAttribution=)]

2019-03-05 ms5469518383470847

这个杂志已经被剔除sci了
articles appearing in the journal are indexed in pubmed/medline; current contents, education; current contents, life sciences; international pharmaceutical abstracts; current index to journals in education; and by proquest and ebsco.

106 0

[GetPortalCommentsPageByObjectIdResponse(id=1086490, encodeId=134410864903c, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086489, encodeId=1cae108648914, content=我的文章大概有几分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850072, encodeId=14938500e261, content=这个杂志已经被剔除sci了 articles appearing in the journal are indexed in pubmed/medline; current contents, education; current contents, life sciences; international pharmaceutical abstracts; current index to journals in education; and by proquest and ebsco. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Tue Mar 05 22:40:06 CST 2019, time=2019-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541242, encodeId=f91c541242d0, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516221, encodeId=a6b751622168, content=markwangzhuo 2012-04-03 发表:: 研究方向：药学教学研究;药学教学设计; 投过两次，3天后都被拒了；第一次是因为不符合其范围；第二次说缺乏原创。国内的教学文章的确缺乏创新，该期刊希望具有中国特色的稿件。目前中国人发的稿件确实很好。, beContent=wangzhuo 2012-04-03 发表:: 研究方向：药学教学研究;药学教学设计; 投过两次，3天后都被拒了；第一次是因为不符合其范围；第二次说缺乏原创。国内的教学文章的确缺乏创新，该期刊希望具有中国特色的稿件。目前中国人发的稿件确实很好。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69061653887, createdName=mxg330, createdTime=Thu Oct 22 02:11:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487706, encodeId=721248e7067e, content=投过两次，3天后都被拒了；第一次是因为不符合其范围；第二次说缺乏原创。国内的教学文章的确缺乏创新，该期刊希望具有中国特色的稿件。目前中国人发的稿件确实很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=011859642, createdName=wangzhuo, createdTime=Tue Apr 03 00:44:00 CST 2012, time=2012-04-03, status=1, ipAttribution=)]

2017-07-14 huabing

马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了

210 0

[GetPortalCommentsPageByObjectIdResponse(id=1086490, encodeId=134410864903c, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086489, encodeId=1cae108648914, content=我的文章大概有几分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850072, encodeId=14938500e261, content=这个杂志已经被剔除sci了 articles appearing in the journal are indexed in pubmed/medline; current contents, education; current contents, life sciences; international pharmaceutical abstracts; current index to journals in education; and by proquest and ebsco. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Tue Mar 05 22:40:06 CST 2019, time=2019-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541242, encodeId=f91c541242d0, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516221, encodeId=a6b751622168, content=markwangzhuo 2012-04-03 发表:: 研究方向：药学教学研究;药学教学设计; 投过两次，3天后都被拒了；第一次是因为不符合其范围；第二次说缺乏原创。国内的教学文章的确缺乏创新，该期刊希望具有中国特色的稿件。目前中国人发的稿件确实很好。, beContent=wangzhuo 2012-04-03 发表:: 研究方向：药学教学研究;药学教学设计; 投过两次，3天后都被拒了；第一次是因为不符合其范围；第二次说缺乏原创。国内的教学文章的确缺乏创新，该期刊希望具有中国特色的稿件。目前中国人发的稿件确实很好。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69061653887, createdName=mxg330, createdTime=Thu Oct 22 02:11:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487706, encodeId=721248e7067e, content=投过两次，3天后都被拒了；第一次是因为不符合其范围；第二次说缺乏原创。国内的教学文章的确缺乏创新，该期刊希望具有中国特色的稿件。目前中国人发的稿件确实很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=011859642, createdName=wangzhuo, createdTime=Tue Apr 03 00:44:00 CST 2012, time=2012-04-03, status=1, ipAttribution=)]

2015-10-22 mxg330

markwangzhuo 2012-04-03 发表::
研究方向：药学教学研究;药学教学设计; 投过两次，3天后都被拒了；第一次是因为不符合其范围；第二次说缺乏原创。国内的教学文章的确缺乏创新，该期刊希望具有中国特色的稿件。目前中国人发的稿件确实很好。

wangzhuo 2012-04-03 发表:: 研究方向：药学教学研究;药学教学设计; 投过两次，3天后都被拒了；第一次是因为不符合其范围；第二次说缺乏原创。国内的教学文章的确缺乏创新，该期刊希望具有中国特色的稿件。目前中国人发的稿件确实很好。

285 0

[GetPortalCommentsPageByObjectIdResponse(id=1086490, encodeId=134410864903c, content=投nature需要什么准备？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086489, encodeId=1cae108648914, content=我的文章大概有几分？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850072, encodeId=14938500e261, content=这个杂志已经被剔除sci了 articles appearing in the journal are indexed in pubmed/medline; current contents, education; current contents, life sciences; international pharmaceutical abstracts; current index to journals in education; and by proquest and ebsco. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Tue Mar 05 22:40:06 CST 2019, time=2019-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541242, encodeId=f91c541242d0, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516221, encodeId=a6b751622168, content=markwangzhuo 2012-04-03 发表:: 研究方向：药学教学研究;药学教学设计; 投过两次，3天后都被拒了；第一次是因为不符合其范围；第二次说缺乏原创。国内的教学文章的确缺乏创新，该期刊希望具有中国特色的稿件。目前中国人发的稿件确实很好。, beContent=wangzhuo 2012-04-03 发表:: 研究方向：药学教学研究;药学教学设计; 投过两次，3天后都被拒了；第一次是因为不符合其范围；第二次说缺乏原创。国内的教学文章的确缺乏创新，该期刊希望具有中国特色的稿件。目前中国人发的稿件确实很好。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=285, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69061653887, createdName=mxg330, createdTime=Thu Oct 22 02:11:00 CST 2015, time=2015-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487706, encodeId=721248e7067e, content=投过两次，3天后都被拒了；第一次是因为不符合其范围；第二次说缺乏原创。国内的教学文章的确缺乏创新，该期刊希望具有中国特色的稿件。目前中国人发的稿件确实很好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=383, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=011859642, createdName=wangzhuo, createdTime=Tue Apr 03 00:44:00 CST 2012, time=2012-04-03, status=1, ipAttribution=)]

2012-04-03 wangzhuo

投过两次，3天后都被拒了；第一次是因为不符合其范围；第二次说缺乏原创。国内的教学文章的确缺乏创新，该期刊希望具有中国特色的稿件。目前中国人发的稿件确实很好。

383 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务